SF3B4 Frameshift Variants Represented a More Severe Clinical Manifestation in Nager Syndrome

Zulvikar Syambani Ulhaq, Gita Vita Soraya, Lola Ayu Istifiani, Syafrizal Aji Pamungkas, William Ka Fai Tse

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)


Nager syndrome (NS) is a rare disease marked with craniofacial and preaxial limb anomalies. In this report, we summarized the current evidence to determine a possible genotype–phenotype association among NS individuals. Twenty-four articles comprising of 84 NS (including 9 patients with a severe form of NS [Rodriguez syndrome]) patients were examined, of which 76% were caused by variants in SF3B4 (OMIM *605593, Splicing Factor 3B, Subunit 4). Within the SF3B4 gene, variants located in exon 3 commonly occurred (20%) from a total identified variant, while hotspot location was identified in exon 1 (12%), and primarily occurred as frameshift variants (64%). Thirty-five distinct pathogenic variants within SF3B4 gene were identified with two common sites, c.1A > G and c.1060dupC in exons 1 and 5, respectively. Although no significant genotype–phenotype association was found, it is notable that patients with frameshift SF3B4 variants and predicted to lead to nonsense-mediated RNA decay (NMD) of the transcripts tended to have a more severe clinical manifestation. Additionally, patients harboring variants in exons 2 and 3 displayed a higher proportion of cardiac malformations. Taken together, this article summarizes the pathogenic variants observed in SF3B4 and provides a possible genotype–phenotype relationship in this disease.

Original languageEnglish
Pages (from-to)1041-1047
Number of pages7
JournalCleft Palate-Craniofacial Journal
Issue number8
Publication statusPublished - Aug 2023

All Science Journal Classification (ASJC) codes

  • Oral Surgery
  • Otorhinolaryngology


Dive into the research topics of 'SF3B4 Frameshift Variants Represented a More Severe Clinical Manifestation in Nager Syndrome'. Together they form a unique fingerprint.

Cite this